Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Schnurr

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Oncoimmunology|May 6, 2015
Induction of immunogenic cell death by targeting RIG-I-like helicases in pancreatic cancerMax Schnurr, Peter Duewell
Oncoimmunology|June 14, 2013
Breaking tumor-induced immunosuppression with 5'-triphosphate siRNA silencing TGFβ and activating RIG-IMax Schnurr, Peter Duewell
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2014
Isolation of intratumoral leukocytes of TLR-stimulated tumor-bearing miceMoritz Rapp, David Anz, Max Schnurr
Current Opinion in Immunology|February 2, 2010
Presentation of tumour antigens by dendritic cells and challenges facedNeil C Robson, Sabine Hoves, Eugene Maraskovsky, et al.
Digestive Diseases (Basel, Switzerland)|October 19, 2012
Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factorsChristian Bauer, Peter Duewell, Hans-Anton Lehr, et al.
Deutsches Arzteblatt International|December 16, 2015
Immunotherapy in TumorsSebastian Kobold, Peter Duewell, Max Schnurr, et al.
Cancer Letters|March 13, 2016
Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancerChristian Bauer, Benjamin Kühnemuth, Peter Duewell, et al.
Blood|October 16, 2004
Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathwayMax Schnurr, Tracey Toy, Amanda Shin, et al.
International Journal of Cancer|August 8, 2013
Multifunctional antitumor molecule 5'-triphosphate siRNA combining glutaminase silencing and RIG-I activationGang Meng, Mao Xia, Chun Xu, et al.
Immunotherapy|April 29, 2015
Strategies to relieve immunosuppression in pancreatic cancerMax Schnurr, Peter Duewell, Christian Bauer, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Oncoimmunology|May 6, 2015
Induction of immunogenic cell death by targeting RIG-I-like helicases in pancreatic cancerMax Schnurr, Peter Duewell
Oncoimmunology|June 14, 2013
Breaking tumor-induced immunosuppression with 5'-triphosphate siRNA silencing TGFβ and activating RIG-IMax Schnurr, Peter Duewell
Methods in Molecular Biology (Clifton, N.J.)|June 25, 2014
Isolation of intratumoral leukocytes of TLR-stimulated tumor-bearing miceMoritz Rapp, David Anz, Max Schnurr
Current Opinion in Immunology|February 2, 2010
Presentation of tumour antigens by dendritic cells and challenges facedNeil C Robson, Sabine Hoves, Eugene Maraskovsky, et al.
Digestive Diseases (Basel, Switzerland)|October 19, 2012
Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factorsChristian Bauer, Peter Duewell, Hans-Anton Lehr, et al.
Deutsches Arzteblatt International|December 16, 2015
Immunotherapy in TumorsSebastian Kobold, Peter Duewell, Max Schnurr, et al.
Cancer Letters|March 13, 2016
Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancerChristian Bauer, Benjamin Kühnemuth, Peter Duewell, et al.
Blood|October 16, 2004
Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathwayMax Schnurr, Tracey Toy, Amanda Shin, et al.
International Journal of Cancer|August 8, 2013
Multifunctional antitumor molecule 5'-triphosphate siRNA combining glutaminase silencing and RIG-I activationGang Meng, Mao Xia, Chun Xu, et al.
Immunotherapy|April 29, 2015
Strategies to relieve immunosuppression in pancreatic cancerMax Schnurr, Peter Duewell, Christian Bauer, et al.
Pageof 7